Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk of Thromboembolic Events in Patients With Polycythemia Vera: A Real-World Observational Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 03, 2026
Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif(®) Efficacy in Multiple Sclerosis (CARE-MS) Program.
Journal: International journal of MS care
Published: August 25, 2015
Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 31, 2013
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Journal: Lancet (London, England)
Published: November 06, 2012
Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: June 15, 2012
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Journal: Blood
Published: October 01, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026